Trade Bill

Debate between Lord Rooker and Baroness Northover

Committee stage & Committee: 2nd sitting (Hansard) & Committee: 2nd sitting (Hansard): House of Lords
Thursday 1st October 2020 Grand Committee

[Lord Rooker (Lab) [V]]

My Lords, I will intervene only briefly, initially to support my noble friend Lord Bassam in some of the examples he gave. Dispute settlement in trade deals is pretty important as is what is put into the deal. I am not clear about—but I hope I am—whether “public services” includes critical infrastructure. As far as I am concerned, the two go together. I would cite energy, for a start, because one can see the problems we are going to have with energy in this country with the collapse of the nuclear deal. We must have a mix. There is a good chance that the lights and the gas may go out and the Government may want to move at some point to take monopoly control of the service. They ought to be able to do that, but there are too many sticky fingers for my liking in the issues involved and therefore I think the idea behind the amendment by my noble friend Lord Bassam is very good.

I want to make a brief point about Amendment 51 on the health service. I thought the speech by the noble Lord, Lord Patel, was devastating with its list of companies. Do not get me wrong, I have no objection to the NHS or other public services using the best available management tools, techniques and individuals to provide services but making use of them is not the same as handing over ownership. That is where one has to draw the line. The noble Lord, Lord Patel, made a very fair point. The public do not care who is providing the service as long as it is there when they need it, free at the point of use. He went on to say that they will care when their taxes go up. That point is when someone, such as the Prime Minister, will say, “You can avoid that by buying some insurance.” It is the slippery road to push us down the insurance route. I know we are all nice people in the Lords but frankly I do not trust the Prime Minister.

[Baroness Northover (LD) [V]]

My Lords, many of the debates here take me back to 2012, and I look forward to the contribution from my former boss, the noble Lord, Lord Lansley. I want to speak in support of Amendment 75 in the name of my noble friend Lady Sheehan. She has laid the amendment out effectively and comprehensively. There has long been tension between those marketing and those purchasing proprietary medicines and generics. Clearly, where pharmaceutical companies invest in research and development they should be rewarded for that, but we also know how expert the industry is at claiming R&D when that is beyond what they have actually done.

This issue plays out in the NHS but also internationally, particularly in developing countries where basic medicines may not be affordable and dependence on generics is vital. As the noble Baroness, Lady Finlay, said, the pandemic has shown how important this is. It reinforces that we are all interlinked. An infection that affects the community in one part of the world is within days potentially spread worldwide. It is in all our interests that disease is countered everywhere, as well as that being the right thing to do.

As my noble friend Lady Sheehan said, Amendment 75 affirms the Government’s right to use internationally agreed safeguards to protect public health, including securing access to more affordable generic medicines. As she said, earlier FTAs often focused on tariffs and trade in goods, while in the past couple of decades FTAs have become more comprehensive. Of course, many such developments are welcome in terms of ensuring standards, as we have been discussing, but provisions can also inappropriately protect monopolistic business. As I have said, genuinely innovative companies have a case, but their role can be exploited. In recognition of this, the WTO’s TRIPS agreement included public health safeguards. These were reaffirmed in the 2001 Doha declaration. Protecting genuine innovation has therefore already been addressed by the WTO, and it is important that these proposals are taken forward. I look forward to hearing the Minister’s response.

Agriculture Bill

Debate between Lord Rooker and Baroness Northover

Report stage & Report: 2nd sitting (Hansard) & Report: 2nd sitting (Hansard): House of Lords
Thursday 17th September 2020 Lords Chamber

[Lord Rooker (Lab) [V]]

My Lords, I avoided devolved issues in Committee and was seeking to avoid them on Report, but I want to come in to support the noble Lord, Lord Wigley.

I have a couple of points to make. One is a general one, and it is no reflection whatever on the Ministers on the Front Bench: the Government do not do devolution. My experience of that comes from 2010 to 2013, some years ago now, when I was chair of the Food Standards Agency and the coalition Government came in. It was quite clear that there was a major problem with their attitude towards devolution, and I think that has carried on. I realise that there are relations between Ministers and they talk to each other, but the government machine does not do devolution.

My more specific point is that I plead guilty on two issues, really. The Agriculture and Horticulture Development Board was one of my babies when I went back to MAFF, or Defra, in 2006. The merger of the six levy boards was done under my watch. Of course, I realised at the time that I was the English farming Minister, not the Great Britain farming Minister, and the issue applied only to England. Furthermore, before that—this shows, I freely admit, that as the years go by I get a bit out of date, and I have had a year when I have not been on the ball, as it were—the cattle tracing service for passports and birth information, located in Workington at the time, was a UK-wide body; indeed, we recruited Welsh speakers. It could be that that has been taken apart and is no longer there, but the fundamental issue behind all this is traceability.

One reason we do it is self-interest, but the reason we were forced to do it by the European Union, as it does elsewhere, is so that we know what animal has been where if a disease breaks out. The issue should not be one of a dispute between devolved Administrations not being able to access the information; it is absolutely fundamental that the traceability of animals, their movements, the feed they have had and other matters is available if an animal disease breaks out—I hope that it does not happen but we have to prepare for the worst—particularly where there is a transfer to humans, or indeed if it is widely spread to other animals because they move around the country, as has just been said, east, west, north and south, and that leads to real problems.

So, first, I fundamentally doubt that the Government really do devolution. Secondly, in an area like this, Clause 32 is quite specific that the Government are in fact taking on board UK-wide information; indeed, relating to Scotland as well. The Minister is going to have to explain exactly what the detail is in terms of the devolved Administrations and how traceability—and the way we need it to operate in an emergency, because it is always an emergency when you actually need it—will actually function.

[Baroness Northover (LD) [V]]

My Lords, we are, again, addressing how matters might be properly devolved. The noble Lord, Lord Wigley, has identified some key challenges in his amendment, and the amendment in the name of the noble Duke, the Duke of Montrose, is complementary to it. It seems to me that these amendments need to be taken very seriously by the Government, who need to assess the implications laid out by noble Lords.